Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis
NCT ID: NCT02252744
Last Updated: 2016-02-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
286 participants
OBSERVATIONAL
2012-11-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Some Risk Factors for Developing RA
NCT03624179
Oral Metagenomic Biomarkers in Rheumatoid Arthritis
NCT02544334
Long-term Observation of Patients With Early Rheumatoid Arthritis
NCT00240136
Atherosclerosis in Rheumatoid Arthritis
NCT00990730
"Translating Articular Biomarkers Into Diagnoses"
NCT06312943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years old or older
* Speaks and understands English and/or Spanish
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Western University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jasmine Yumori
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jasmine W Yumori, OD FAAO
Role: PRINCIPAL_INVESTIGATOR
Western University of Health Sciences
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WesternU-12irb027
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.